Clinical Trials · NCT01638247
Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- GBG Forschungs GmbH
- Enrollment
- 56
- Start date
- Aug 2012
- Locations
- 1 site, Germany
- Primary endpoint
- Estradiol blood concentation